The global endometriosis market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. More Info:- https://www.imarcgroup.com/endometriosis-market

1. Global Endometriosis
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Endometriosis Market:
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast
2024-2032," the global endometriosis market size reached US$ 2.4 Billion in
2023.
Endometriosis refers to a medical condition that causes excessive growth of
endometrial tissues in various regions outside the uterus, such as the fallopian
tube, uterine cavity, and ovaries. Chronic pelvic pain, fatigue, bloating,
constipation, infertility, and discomfort during urination are some of the
common symptoms.
It is diagnosed through physical examinations of the pelvic region and various
imaging tests, such as ultrasound and magnetic resonance imaging (MRI).
Endometriosis is treated using over-the-counter medications, fertility
treatments, hormonal therapy, and surgical procedures. These treatments aid
in alleviating pain, increasing the chance of pregnancy, minimizing
complications, improving the overall quality of life, and managing various
symptoms, such as inflammation, nausea, and scarring.
Request for a PDF sample of this report:
https://www.imarcgroup.com/endometriosis -market/requestsample

4. Report Description
Global Endometriosis Market Trends:
The rising prevalence of endometriosis due to genetics, hormonal imbalance, retrograde mensuration, immune
system dysfunction, and environmental toxins is one of the primary factors driving the market growth. In addition
to this, the increasing awareness among the masses regarding early diagnosis of endometriosis to prevent
various complications, such as ovarian cysts, adhesion, and bladder dysfunction, is acting as another growth-
inducing factor. Furthermore, rising demand for minimally invasive (MI) surgical procedures, such as laparoscopy,
which reduces pain and scarring, promote faster recovery, and minimize the risk of infections, blood loss, and
surgical complications, is providing an impetus to the market growth. Additionally, the recent development of non-
surgical treatment options, such as ultrasound therapy which utilizes high-intensity focused ultrasound (HIFU) to
destroy endometrial tissues at high precision and eliminate the need for medications and hormonal treatments, is
positively influencing the market growth. Moreover, growing initiatives by several governments and international
organizations, such as the Endometriosis Association and World Endometrial Society, to increase awareness and
improve access to care for women are creating a positive outlook for market growth. Other factors, including
rising healthcare expenditure, rapid advancements in diagnostic techniques, and increasing investment in the
research and development (R&D) of novel treatment methods, are anticipated to drive the market growth.
Looking forward, the market is expected to reach US$ 3.7 Billion by 2032, exhibiting a CAGR of 4.71%
during 2024-2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/endometriosis-market

5. Report
Segmentation
Breakup by Type:
• Superficial Peritoneal Lesion
• Endometrioma
• Deeply Infiltrating Endometriosis
• Others
Breakup by Diagnosis and Treatment:
• Diagnosis
o Ultrasound
o Pelvic Exam
o Laparoscopy
o Magnetic Resonance Imaging (MRI)
o Hysteroscopy
o Sonohysterography
• Treatment
o Hormonal Therapy

6. Report
Segmentation
o Pain Management
o Conservative Surgery
Breakup by End Users:
• Hospitals
• Homecare
• Speciality Centers
• Others
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Abbott Laboratories
• AbbVie Inc.
• Bayer AG
• Debiopharm Group
• Gedeon Richter Plc
• Kissei Pharmaceutical Co. Ltd.
• Myovant Sciences GmbH
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.

8. Key Questions
Answered in
the Report
How has the global endometriosis market performed so far,
and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the
global endometriosis market?
What is the impact of each driver, restraint, and opportunity
on the global endometriosis market?
What are the key regional markets?
Which countries represent the most attractive endometriosis
market?
What is the breakup of the market based on the type?
Which is the most attractive type in the endometriosis
market?

9. Key Questions
Answered in
the Report
What is the breakup of the market based on the diagnosis and
treatment?
Which is the most attractive diagnosis and treatment in the
endometriosis market?
What is the breakup of the market based on the end users?
Which is the most attractive end users in the endometriosis
market?
What is the competitive structure of the market?
Who are the key players/companies in the global
endometriosis market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Endometriosis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Superficial Peritoneal Lesion
6.1.1 Mark et Trends
6.1.2 Mark et Forecast
6.2 Endometrioma
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
6.3 Deeply Infiltrating Endometriosis
6.3.1 Mark et Trends
6.3.2 Mark et Forecast

11. Table of
Contents
6.4 Others
6.4.1 Mark et Trends
6.4.2 Mark et Forecast
7 Market Breakup by Diagnosis & Treatment
7.1 Diagnosis
7.1.1 Mark et Trends
7.1.2 Key Segments
7.1.2.1 Ultrasound
7.1.2.2 Pelvic Exam
7.1.2.3 Laparoscopy
7.1.2.4 Magnetic Resonance Imaging (MRI)
7.1.2.5 Hysteroscopy
7.1.2.6 Sonohysterography
7.1.3 Mark et Forecast
7.2 Treatment
7.2.1 Mark et Trends
7.2.2 Key Segments
7.2.2.1 Hormonal Therapy
7.2.2.2 Pain Management
7.2.2.3 Conservative Surgery
7.2.3 Mark et Forecast
8 Market Breakup by End Users
8.1 Hospitals
8.1.1 Mark et Trends
8.1.2 Mark et Forecast
8.2 Homecare
8.2.1 Mark et Trends
8.2.2 Market Forecast
For more information, visit :
https://www.imarcgroup.com/endometriosis -market/toc

12. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

13. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com